• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1999 Fiscal Year Final Research Report Summary

Molecular Pathology of Cartilage destruction in Rheumatoid Arthritis

Research Project

Project/Area Number 10470051
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Human pathology
Research InstitutionKeio University

Principal Investigator

OKADA Yasunori  Dept.of Pathology, Keio University, Professor, 医学部, 教授 (00115221)

Project Period (FY) 1998 – 1999
KeywordsRheumatoid arthritis / Osteoarthritis / Matrix metalloproteinase / Cartilage destruction / Activation of proMMP / MMP inhibitors / TIMP
Research Abstract

Degradation of the extracellular matrix (ECM) is an essential step to the destruction of articular cartilage in rheumatoid athritis (RA), and members of the matrix metalloproteinase (MMP) gene family are involved in the degradation. In the present studies, we characterized the biochemical properties of some MMP species and examined their functions in the destruction of the cartilage in RA joints. In addition, synthetic MMP inhibitors and tissue inhibitor of metalloproteinases 3 (TIMP-3)-inducible drug were developed by collaboration with pharmaceutical companies. The major results are as follows:
(1). Activation of proMMP-2 mediated by membrane-type1 MMP (MT1-MMP) was accelerated in the presence of TIMP-2, and thus TIMP-2 was considered to be essential to the efficient activation of proMMP-2 on the cell membranes. We also demonstrated that MT1-MMP cleaves aggrecan at three sites in the interglobular domain and MT3-MMP degrades the ECM components such as type III collagen and aggrecan. O … More n the other hand, the activities of MT1-MMP and MT3-MMP were not inhibited by TIMP-1. MT-MMP was shown to be shed from the cell membranes of tumor cells treated with concanvalin A.
(2). ProMMP-2 was efficiently activated in RA synovial tissues and its activation ratio directly correlated with the expression levels of MT1-MMP among MT1, 2, 3-MMPs. MT1-MMP was expressed in the lining cells of RA synovial membrane and gelatinolytic activity was detected by in situ zymography in the lining cell layer.
(3). When steady state levels of MMP-1, 2, 3, 7, 8, 9, 13 and TIMP-1, 2 in synovial fluids were assayed by sandwich enzyme immunoassays, the levels of MMP 1, 2, 3, 8, 9 and TIMP-1 were significantly higher in RA than in OA. The molar ratio was significantly higher in RA than in OA, and metalloproteinase activity was detected with a direct correlation to MMP/TIMP molar ratio, suggesting an imbalance in favor of proteinase.
(4). By collaboration with a pharmaceutical company, we developed synthetic inhibitors more selective to MT1-MMP, We also demonstrated that pentosan polysulfate stimulates RA synovial fibroblasts to produce TIMP-3 by the posttranscriptional level. Less

  • Research Products

    (17 results)

All Other

All Publications (17 results)

  • [Publications] Ohta S.: "Expression of matrix metalloproteinase 7(matrilysin) in human osteoarthritic cartilage"Lab. Invent. 78. 79-87 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Oshita T.: "TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads"J. Biol. Chem.. 273. 16098-16103 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shimada T.: "Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase"Euro. J. Biochem. 262. 907-914 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Takizawa M.: "Production of tissue inhibitor of metalloproteinases-3 is selectively enhanced by calcium pentosan in human rheumatoid synovial fibroblasts."Arthritis Rheum.. (in press). (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yoshiharan Y.: "Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids form patients with rheumatoid arthritis or osteoarthritis"Ann. Rheum. Dis.. (in press). (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yamanaka H.: "Expression and tissue localization of membrane-types 1,2 and 3 matrix metalloproteinases in rheumatoid arthritis"Lab. Invest.. (in press). (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Okada Y: "In: Methods in Biology-Matrix Metalloproteinase Protocols. Ed. by I Clark. Human Press Inc., Totowa, USA"Immunohistochemistry of MMPs and TIMPs. (in press). (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Okada Y.: "In Textbook of Rheumatology. Ed. by Kelley W. N., Harris E.D., Jr. Ruddy S. and Sledge C. B. 6th edition, W. B. Saunders Company. Philadelphia, pp"Proteinases and matrix degradation. (in press). (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Okada Y.: (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ohta S., Imai K., Yamashita K., Matsumoto T., Azumano I. And Okada Y.: "Expression of matrix. Metalloproteinase 7(matlilysin) in human osteoarthritic cartilage."Lab. Invest.. 78. 79-87 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kinoshita T., Sato H., Okada A., Ohuchi E., Imai K, Okada Y. and Seiki M.: "TIMP-2 promotes activation of progelatinase A by membrane-type l matrix metalloproteinase immobilized on agarose beads."J. Biol. Chem.. 273. 16098-16103

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shimada T., Nakamura H., Ohuchi E., Fujii Y., Murakami Y., Sato H., Seiki M. and Okada Y.: "Characterization of a truncated recombinant from of human membrane type 3 matrix metalloproteinase."Eur. J. Biochem.. 262. 907-914 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Takizawa M., Ohuchi E., Yamanaka H., Nakamura H., Ikeda E., Ghosh P. and Okada Y.: "Production of tissue inhibitor of metalloproteinases-3 is selectively enhanced by calcium pentosan polysulfate in human rheumatoid synovial fibroblasts"Arthritis Rheum. (in press). (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yoshihara Y., Nakamura H., Obata K., Yamada H., Hayakawa T., Fujikawa K. and Okada Y.: "Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis."Ann. Rheum Dis.. (in press). (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yamanaka H., Makino K., Takizawa M., Nakamura H., Fujimoto N., Moriya H., Nemori R., Sato H., Seiki M. and Okada Y.: "Expression and tissue localization of membrane-types l, 2 and 3 matrix metalloproteinases in rheumatoid arthriitis."Lab. Invest.. (in press). (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Okada Y.: "Immunohistochemistry of MMPs and TIMPs"Methods in Biology-Matrix Metalloproteinase Protocols. Ed. By I Cark. Human Press Inc., Totowa, USA. (in press). (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Okada Y.: "Proteinases and matrix degradation. Textbook of Rheumatology. Ed by Kelley W. N., Harris E. D., Jr., Ruddy S. and Sledge C. B. 6th edition"W. B. Saunders Company. Philadelphia (in press). (2000)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2001-10-23  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi